# To Compare the Efficacy of Carbepenem Versus Carbepenem Plus GM-CSF in Difficult To Treat Spontaneous Bacterial Peritonitis

> **NCT02468089** · NA · COMPLETED · sponsor: **Institute of Liver and Biliary Sciences, India** · enrollment: 146 (actual)

## Conditions studied

- Spontaneous Bacterial Peritonitis

## Interventions

- **DRUG:** Carbepenem
- **DRUG:** Albumin
- **DRUG:** GMCSF (of Granulocyte-Monocyte Colony-Stimulating Factor) .

## Key facts

- **NCT ID:** NCT02468089
- **Lead sponsor:** Institute of Liver and Biliary Sciences, India
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05-01
- **Primary completion:** 2017-08-31
- **Final completion:** 2017-08-31
- **Target enrollment:** 146 (ACTUAL)
- **Last updated:** 2017-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02468089

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02468089, "To Compare the Efficacy of Carbepenem Versus Carbepenem Plus GM-CSF in Difficult To Treat Spontaneous Bacterial Peritonitis". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT02468089. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*